nContact Surgical

Morrisville, United States Founded: 2005 • Age: 21 yrs Acquired By AtriCure
Cardiac ablation devices for atrial fibrillation treatment are developed.
Request Access

About nContact Surgical

nContact Surgical is a company based in Morrisville (United States) founded in 2005 was acquired by AtriCure in October 2015.. nContact Surgical has raised $53.15 million across 9 funding rounds from investors including AtriCure, Harbert Management and ZMV Associates. The company has 14 employees as of December 31, 2015. nContact Surgical operates in a competitive market with competitors including AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others.

  • Headquarter Morrisville, United States
  • Employees 14 as on 31 Dec, 2015
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $53.15 M (USD)

    in 9 rounds

  • Latest Funding Round
    $13 M (USD), Series E

    Mar 06, 2013

  • Investors
    AtriCure

    & 7 more

  • Employee Count
    14

    as on Dec 31, 2015

  • Acquired by
    AtriCure

    (Oct 05, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of nContact Surgical

nContact Surgical has successfully raised a total of $53.15M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $13 million completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 9
  • Last Round Series E — $13.0M
  • First Round

    (01 Jul 2005)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2013 Amount Series E - nContact Surgical Valuation

investors

Jan, 2012 Amount Debt – Conventional - nContact Surgical Valuation

investors

Nov, 2010 Amount Series D - nContact Surgical Valuation Harbert Management
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in nContact Surgical

nContact Surgical has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include AtriCure, Harbert Management and ZMV Associates. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Infrastructure, hedge, private equity, and debt fund focused on multiple sectors
Founded Year Domain Location
-
Founded Year Domain Location
Early-stage life sciences and tech focused VC firm funding companies in the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by nContact Surgical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - nContact Surgical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ncontact Surgical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of nContact Surgical

nContact Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, AtaCor Medical, Kestra Medical Technologies, CardioFocus and Biosense Webster, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
domain founded_year HQ Location
An implantable pacemaker system is developed for cardiac pacing therapy.
domain founded_year HQ Location
Medical devices are developed to support cardiovascular patients at risk.
domain founded_year HQ Location
Endoscopic catheter for atrial fibrillation ablation is developed.
domain founded_year HQ Location
Mapping catheters for cardiac arrhythmia treatment are developed.
domain founded_year HQ Location
Wireless cardiac pacing devices are developed for left ventricle stimulation.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ncontact Surgical

Frequently Asked Questions about nContact Surgical

When was nContact Surgical founded?

nContact Surgical was founded in 2005.

Where is nContact Surgical located?

nContact Surgical is headquartered in Morrisville, United States.

Who is the current CEO of nContact Surgical?

John Funkhouser is the current CEO of nContact Surgical.

Is nContact Surgical a funded company?

nContact Surgical is a funded company, having raised a total of $53.15M across 9 funding rounds to date. The company's 1st funding round was a Series D of $16.15M, raised on Jul 01, 2005.

How many employees does nContact Surgical have?

As of Dec 31, 2015, the latest employee count at nContact Surgical is 14.

What does nContact Surgical do?

nContant develops cardiac ablation devices. The company has developed EPi-Sense and Numeris Coagulation System and VisiTrax epicardial ablation device for treatment of atrial fibrillation. The EPi-Sense and Numeris Coagulation System with VisiTrax have CE Mark Approval in Europe for the coagulation of cardiac tissue for the treatment of atrial fibrillation and atrial flutter. It integrates suction, perfusion, and radiofrequency energy to ensure cardiac tissue contact and energy transmission to create linear lesions on a beating heart. Numeris with VisiTrax is also indicated for endoscopic coagulation of cardiac tissue in the United States.

Who are the top competitors of nContact Surgical?

nContact Surgical's top competitors include AtaCor Medical, AtriCure and CardioFocus.

Who are nContact Surgical's investors?

nContact Surgical has 8 investors. Key investors include AtriCure, Harbert Management, ZMV Associates, Intersouth Partners, and Finistere Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available